vimarsana.com
Home
Live Updates
Astria Therapeutics : - 2024 Proxy Statement : vimarsana.com
Astria Therapeutics : - 2024 Proxy Statement : vimarsana.com
Astria Therapeutics : - 2024 Proxy Statement
ASTRIA THERAPEUTICS, INC.
75 State Street, Suite 1400
Boston, MA 02109
NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Joanne Beck ,
Hugh Cole ,
Jillc Milne ,
Gregg Lapointe ,
Wilmer Cutler Pickering Hale ,
Michael Kishbauch ,
Sunil Agarwal ,
Fred Callori ,
Ernst Young ,
Roche Holdings Inc ,
Biology At Cornell University ,
Myokardia Inc ,
Exchange Commission ,
Equiniti Trust Company ,
Corporation Law Of The State Delaware ,
Alliance Advisors ,
Board Of Directors Astria Therapeutics Inc ,
Astria Therapeutics Inc ,
Arvinas Inc ,
Meeting Of Stockholders Astria Therapeutics Inc ,
Bristol Myers Squibb ,
Global Head Of Clinical Development ,
Sana Biotechnology Inc ,
Genentech Inc ,
Calithera Biosciences Inc ,
Ultragenyx Pharmaceutical Inc ,
Juno Therapeutics Inc ,
Astria Therapeutics ,
Annual Meeting ,
Incentive Plan ,
Internet Availability ,
Proxy Materials ,
Annual Report ,
Chief Executive Officer ,
Notice Regarding ,
Corporate Secretary ,
Directors Recommendation ,
Second Amended ,
Can Vote ,
Seriesx Preferred Stock ,
Shares Held ,
Measures Considered ,
Beach Proposal ,
Counting Votes ,
Changing Your Vote ,
Proxy Solicitation ,
Current Report ,
General Corporation Law ,
Classi Directors ,
Kenneth Bate ,
Jonathan Violin ,
Each Class ,
Three Year Term Expiring ,
Executive Vice President ,
Chief Development Officer ,
Sana Biotechnology ,
Juno Therapeutics ,
Sofinnova Ventures ,
Chief Medical Officer ,
Senior Vice President ,
Roche Holdings ,
Global Head ,
Clinical Development ,
Infectious Diseases ,
Vice President ,
Genentech Drug ,
Calithera Biosciences ,
Cornell University ,
Markets ,